Pharmaceutical Process Validation and Quality by Design (QbD)

This session focuses on process validation and the application of Quality by Design principles in pharmaceutical development and manufacturing. It covers risk assessment, critical quality attributes (CQAs), critical process parameters (CPPs), design of experiments (DoE), and control strategies to ensure consistent product quality. Topics include lifecycle management, continuous improvement, regulatory expectations, and integration of QbD into formulation and process development. The session highlights how systematic design approaches enhance efficiency, reduce variability, and support regulatory compliance.

    Related Conference of Pharmaceutical Process Validation and Quality by Design (QbD)

    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    February 15-16, 2027

    23rd Annual Congress on Pharmacology and Toxicology

    Paris, France
    April 08-09, 2027

    21st World Drug Delivery Summit

    Vienna, Austria
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France
    April 27-28, 2027

    19th World Drug Delivery Summit

    Paris, France

    Pharmaceutical Process Validation and Quality by Design (QbD) Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in